首页> 外文期刊>Bioorganic and medicinal chemistry >Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-((alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyp henyl)methyl)-N-ethyl-N-phenylbenzamide and (-)-4-((alphaR)-alpha-(2S,5S)-dimethylpi
【24h】

Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-((alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyp henyl)methyl)-N-ethyl-N-phenylbenzamide and (-)-4-((alphaR)-alpha-(2S,5S)-dimethylpi

机译:具有mu和δ阿片受体亲和力的二芳基二甲基哌嗪配体:(+)-4-((alphaR)-alpha-(4-烯丙基-(2S,5S)-二甲基哌嗪-1-基)-(3-羟基对苯基)的合成)甲基)-N-乙基-N-苯基苯甲酰胺和(-)-4-((alphaR)-alpha-(2S,5S)-dimethylpi

获取原文
获取原文并翻译 | 示例
           

摘要

We have explored the synthesis of compounds that have good affinity for both mu- and delta-opioid receptors from the (alphaR,2S,5S) class of diaryldimethylpiperazines. These non-selective compounds were related to opioids that have been found to interact selectively with mu- or delta-opioid receptors as agonists or antagonists. In our initial survey, we found two compounds, (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyp henyl)methyl]-N-ethyl-N-phenylbenzamide (14) and its N-H relative, (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)met hyl]-N-ethyl-N-phenylbenzamide (15), that interacted with delta-receptors with good affinity, and, as we hoped, with much higher affinity at mu-receptors than SNC80. The relative configuration of the benzylic position in (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethyl-1-piperazinyl)-(3-methoxyp henyl)methyl]-benzyl alcohol (10) was determined by X-ray crystallographic analysis of a crystal that was an unresolved twin. The absolute stereochemistry of that benzylic stereogenic center was unequivocally derived by the X-ray crystallographic analysis from the two other centers of asymmetry in the molecule that were known. Those were established from the synthesis via a dipeptide cyclo-L-Ala-L-Ala in which the absolute stereochemistry was established.
机译:我们已经从二芳基二甲基哌嗪的(alphaR,2S,5S)类中探索了对mu和阿片类阿片受体均具有良好亲和力的化合物的合成。这些非选择性化合物与阿片类物质有关,已发现它们与作为激动剂或拮抗剂的mu-或δ阿片类受体选择性相互作用。在我们的初步调查中,我们发现了两种化合物,(+)-4-[(alphaR)-α-(4-烯丙基-(2S,5S)-二甲基哌嗪-1-基)-(3-羟基对苯基)甲基]- N-乙基-N-苯基苯甲酰胺(14)及其NH相对的(-)-4-[(alphaR)-alpha-(2S,5S)-二甲基哌嗪-1-基)-(3-羟基苯基)甲基]- N-乙基-N-苯基苯甲酰胺(15)与δ受体具有良好的亲和力,并且,正如我们希望的那样,对mu受体的亲和力比SNC80高得多。 (+)-4-[(alphaR)-α-(4-烯丙基-(2S,5S)-二甲基-1-哌嗪基)-(3-甲氧基对苯基)甲基]-苄醇中苄基位置的相对构型(10)是通过对未解析的孪晶的晶体的X射线晶体学分析确定的。通过X射线晶体学分析明确地从已知分子中的其他两个不对称中心衍生出该苄基立体生成中心的绝对立体化学。这些是通过二肽环-L-Ala-L-Ala从合成中建立的,其中建立了绝对立体化学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号